CME Group Inc (CME) Shares Sold by Greenleaf Trust

Greenleaf Trust lowered its stake in shares of CME Group Inc (NASDAQ:CME) by 24.8% during the first quarter, Holdings Channel reports. The fund owned 1,976 shares of the financial services provider’s stock after selling 650 shares during the period. Greenleaf Trust’s holdings in CME Group were worth $325,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of CME Group by 8.2% in the 4th quarter. BlackRock Inc. now owns 24,250,752 shares of the financial services provider’s stock valued at $4,562,052,000 after purchasing an additional 1,828,640 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in shares of CME Group by 18,502.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 16,220,459 shares of the financial services provider’s stock valued at $86,000 after purchasing an additional 16,133,266 shares during the last quarter. Janus Henderson Group PLC boosted its stake in shares of CME Group by 10.7% in the 1st quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock valued at $1,025,278,000 after purchasing an additional 603,645 shares during the last quarter. FMR LLC boosted its stake in shares of CME Group by 114.7% in the 4th quarter. FMR LLC now owns 6,198,088 shares of the financial services provider’s stock valued at $1,165,984,000 after purchasing an additional 3,310,989 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of CME Group by 12.9% in the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock valued at $885,776,000 after purchasing an additional 537,917 shares during the last quarter. 84.69% of the stock is currently owned by hedge funds and other institutional investors.

CME Group stock opened at $187.92 on Friday. CME Group Inc has a fifty-two week low of $157.35 and a fifty-two week high of $197.08. The company has a market cap of $67.09 billion, a P/E ratio of 27.55, a PEG ratio of 4.27 and a beta of 0.32. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.04 and a current ratio of 1.04.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.02. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The business had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same quarter last year, the firm earned $1.86 EPS. CME Group’s quarterly revenue was up 6.4% compared to the same quarter last year. Analysts expect that CME Group Inc will post 6.62 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend is Friday, June 7th. CME Group’s payout ratio is 43.99%.

Several research analysts have recently issued reports on the stock. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday, April 17th. BidaskClub raised shares of CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, April 18th. Barclays raised their target price on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research note on Thursday. UBS Group reduced their target price on shares of CME Group from $179.00 to $175.00 and set a “neutral” rating on the stock in a research note on Thursday, May 2nd. Finally, ValuEngine lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 20th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $190.00.

In related news, insider Kathleen M. Cronin sold 8,340 shares of CME Group stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $167.54, for a total transaction of $1,397,283.60. Following the transaction, the insider now owns 41,604 shares of the company’s stock, valued at approximately $6,970,334.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $168.27, for a total transaction of $420,675.00. Following the sale, the chief financial officer now owns 35,354 shares in the company, valued at $5,949,017.58. The disclosure for this sale can be found here. Insiders have sold a total of 43,449 shares of company stock worth $7,665,179 in the last three months. 1.20% of the stock is owned by insiders.

WARNING: This article was published by Stock Observer and is the property of of Stock Observer. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://www.thestockobserver.com/2019/05/25/cme-group-inc-cme-shares-sold-by-greenleaf-trust.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: How to execute a trade ex-dividend strategy?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.